Gene Therapy in Ophthalmology

Gene therapy in ophthalmology represents a cutting-edge approach aimed at treating inherited and acquired eye diseases at the genetic level. This innovative technique involves delivering therapeutic genes into target cells of the eye using viral vectors or other delivery systems. By correcting genetic mutations or introducing beneficial genes, gene therapy holds promise for conditions such as retinal dystrophies, inherited retinal diseases, and even some forms of glaucoma. Clinical trials have shown encouraging results, with potential benefits including improved visual function and slowed disease progression. Ongoing research focuses on optimizing delivery methods, enhancing safety profiles, and expanding treatment options for a broader range of ocular disorders.

    Related Conference of Gene Therapy in Ophthalmology

    October 17-18, 2024

    24th Global Ophthalmologists Annual Meeting

    London, UK
    February 24-25, 2025

    9th World Congress on Eye and Vision

    Madrid, Spain
    March 17-18, 2025

    39th European Ophthalmology Congress

    Berlin, Germany
    April 07-08, 2025

    6th World congress on Ophthalmology and Optometry

    Amsterdam, Netherlands
    April 29-30, 2025

    35th International Congress on Vision Science and Eye

    Barcelona, Spain
    April 29-30, 2025

    6th World Congress on Ophthalmology and Vision Science

    Barcelona, Spain
    June 12-13, 2025

    6th International Conference on Optometry

    London, UK

    Gene Therapy in Ophthalmology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in